As of 2025-04-22, the Intrinsic Value of Athira Pharma Inc (ATHA) is -12.42 USD. This Athira valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.25 USD, the upside of Athira Pharma Inc is -5,092.14%.
Based on its market price of 0.25 USD and our intrinsic valuation, Athira Pharma Inc (ATHA) is overvalued by 5,092.14%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -12.42 - -12.42 | -12.42 | -5,092.14% |
| P/E | (29.95) - (40.42) | (33.77) | -13678.6% |
| DDM - Stable | (17.86) - (43.09) | (30.47) | -12353.4% |
| DDM - Multi | (14.96) - (28.56) | (19.69) | -8016.7% |
| Market Cap (mil) | 9.71 |
| Beta | 2.31 |
| Outstanding shares (mil) | 39.04 |
| Enterprise Value (mil) | -38.73 |
| Market risk premium | 4.60% |
| Cost of Equity | 11.46% |
| Cost of Debt | 5.00% |
| WACC | 7.56% |